Kelvin Wu has served on our board of directors as our Executive Chairman since 2018. With over 12 years experience as an investment banker, Mr. Wu has led a team in sponsoring and underwriting 25+ IPOs, including some of the most over-subscribed and iconic deals in the Asian financial market history.

Snir co-founded AID Genomics with Kelvin and has served as CEO and director since 2018. Prior to that, he was the CEO and Founder of Zano's World, a global homeland security service provider in the field of IoT and cybersecurity.

Andrew Rickards serves as a Director at AID Genomics. Mr. Rickards has held senior positions in the financial services sector, including Managing Director and co-Head of Telecoms, Media, and Technology Investment Banking, Goldman Sachs Asia, and Head of Asia for Rothschild & Co

Dr. Izhak Haviv serves as Chief Scientific Officer of AID Genomics. Dr. Haviv is also an honorary associate at the University of Melbourne and a visiting scientist at Peter MacCallum Cancer Centre.

Shimon Gross is the Executive Vice President of Genomics at AID Genomics. Dr. Gross is an accomplished biomedical sales, marketing and business development professional.

Itai Cohen serves as Chief Financial Officer at AID Genomics. Mr. Cohen has over 10 years’ experience holding key positions in the Israeli financial markets, including acting as senior manager and C-Level positions in global firms.

Dor Sultan serves as CMO at AID Genomics. Over the past 10 years Mr. Sultan has held several senior management positions, having extensive experience in business strategy, media, marketing and public relations.

Dr. Gertler serves as our Senior VP of Clinical Affairs. Prior to joining us, Dr. Gertler served as a clinical laboratory director of the pathology department at Hadassah Medical Center both at the Ein Karem and the Mount Scopus sites of Hadassah.

Yannay serves as Chief Operations Officer at AID Genomics and has over 10 years of experience in the Israeli health market.